Skip to main content
OpenTrials
Completed

NCT Number: NCT07442123

Peripheral Nerve Blocks and Postoperative Pain and Mobilization After Total Knee Arthroplasty

Total knee arthroplasty (TKA) is frequently associated with significant postoperative pain, which may delay early mobilization and negatively affect functional recovery. Peripheral nerve blocks are widely used as part of multimodal analgesia strategies to improve postoperative pain control while minimizing opioid consumption and preserving motor function. Different peripheral nerve block techniques may result in varying analgesic efficacy and mobilization outcomes.

The aim of this prospective observational study is to compare the effects of commonly used peripheral nerve block techniques on postoperative pain control and early mobilization in patients undergoing total knee arthroplasty under spinal anesthesia. Patients receiving fascia iliaca plane block are compared with those receiving a combination of adductor canal block and interspace between the popliteal artery and capsule of the knee (IPACK) block.

The primary outcome is postoperative opioid consumption within the first 24 hours after surgery. Secondary outcomes include postoperative pain scores assessed at predefined time intervals, early mobilization parameters, and opioid-related adverse effects. The findings of this study are intended to contribute to optimizing analgesic strategies and improving early functional recovery following total knee arthroplasty.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

SBU Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Ankara, 06200, Turkey (Türkiye)

About this study

Total knee arthroplasty (TKA) is a commonly performed orthopedic procedure associated with moderate to severe postoperative pain that may impair early mobilization and delay rehabilitation. Effective postoperative analgesia is essential to facilitate early functional recovery, reduce opioid consumption, and minimize postoperative complications. Multimodal analgesia strategies incorporating peripheral nerve blocks have become increasingly important in postoperative pain management following TKA.

Peripheral nerve block techniques aim to provide effective analgesia while preserving motor function to support early ambulation. Traditional proximal blocks may provide adequate pain relief but can be associated with motor weakness that limits mobilization. More distal techniques, such as the adductor canal block, are increasingly preferred due to their motor-sparing characteristics. The interspace between the popliteal artery and capsule of the knee (IPACK) block has been introduced to improve posterior knee analgesia without affecting motor function. The fascia iliaca plane block represents another commonly used regional anesthesia technique; however, comparative clinical data regarding analgesic efficacy and mobilization outcomes between these approaches remain limited.

This prospective observational study is conducted in patients undergoing unilateral total knee arthroplasty under spinal anesthesia. Participants receive either fascia iliaca plane block or a combination of adductor canal block and IPACK block as part of routine clinical practice. The study evaluates postoperative outcomes during the first 24 hours following surgery.

The primary objective is to compare total opioid consumption within the first 24 postoperative hours between the two peripheral nerve block techniques. Secondary objectives include assessment of postoperative pain intensity using the Numeric Rating Scale (NRS) at predefined time points, evaluation of early mobilization parameters, and comparison of opioid-related adverse effects.

Pain assessments are performed at 0, 2, 6, 12, and 24 hours postoperatively. Early mobilization is evaluated using standardized functional assessments, including walking ability and motor function tests of quadriceps and ankle dorsiflexor muscles. All patients receive standardized spinal anesthesia and postoperative patient-controlled analgesia to ensure comparable perioperative management.

The results of this study are expected to provide clinical evidence regarding the comparative effectiveness of commonly used peripheral nerve block techniques and to support optimization of postoperative analgesia protocols aimed at improving recovery after total knee arthroplasty.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients aged 18-80 years
  • Scheduled for elective unilateral total knee arthroplasty
  • Surgery performed under spinal anesthesia
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Ability to understand the study procedures and provide informed consent

Exclusion criteria

  • Refusal to participate
  • Contraindications to spinal anesthesia or peripheral nerve block
  • Known allergy to local anesthetics
  • Chronic opioid use or opioid dependence
  • Preexisting neurological or neuromuscular disorders affecting lower extremities
  • Cognitive impairment preventing pain assessment
  • Infection at the injection site
  • Coagulopathy or ongoing anticoagulant therapy contraindicating regional anesthesia

Treatment and study plan

Fascia Iliaca Plane Block

Procedure

Ultrasound-guided fascia iliaca plane block is performed under sterile conditions prior to surgery as part of perioperative analgesia. Using an in-plane technique with a high-frequency linear ultrasound probe, the needle is advanced beneath the fascia iliaca, and 40 mL of 0.25% bupivacaine is injected incrementally after negative aspiration to achieve spread within the fascia iliaca compartment.

Adductor Canal Block + IPACK Block

Procedure

An ultrasound-guided adductor canal block followed by an interspace between the popliteal artery and capsule of the knee (IPACK) block is performed prior to surgery as part of perioperative analgesia. The adductor canal block is administered using 20 mL of 0.25% bupivacaine injected adjacent to the femoral artery beneath the sartorius muscle. Subsequently, the IPACK block is performed with 20 mL of 0.25% bupivacaine injected into the tissue plane between the popliteal artery and the posterior capsule of the knee under ultrasound guidance.

Primary outcomes

  1. Total Postoperative Opioid Consumption

    Time frame: Within the first 24 hours after surgery

    Total opioid consumption administered via patient-controlled analgesia (PCA) during the first 24 hours following total knee arthroplasty. Opioid use is recorded as the cumulative dose of morphine (mg) delivered by the PCA device.

Secondary outcomes

  1. Postoperative Pain Intensity (NRS Score)

    Time frame: 0, 2, 6, 12, and 24 hours after surgery

    Postoperative pain intensity assessed using the Numeric Rating Scale (NRS), where 0 indicates no pain and 10 indicates the worst imaginable pain. Pain scores are recorded at predefined postoperative time points under resting conditions.

  2. Early Mobilization Performance

    Time frame: 24 hours after surgery

    Early postoperative mobilization assessed using standardized functional evaluations, including walking ability, quadriceps muscle strength, and ankle dorsiflexor motor function scores recorded at postoperative assessment.

Sponsors and collaborators

Lead sponsor

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Other

Registry information

Official study title

Comparison of the Effects of Peripheral Nerve Blocks Applied in Total Knee Arthroplasty on Pain Control and Mobilization: A Prospective Observational Study

Important dates

Study start
2022
Primary completion
2024
Study completion
2025
First posted
Mar 2, 2026
Registry last updated
Mar 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.